Skip to main content
Robert Louis Steinbrook, MD, Internal Medicine, Lincoln, MA

Robert LouisSteinbrookMD

Internal Medicine Lincoln, MA

Physician

Are you Dr. Steinbrook?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 14 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    8 Pierce Hill Rd
    Lincoln, MA 01773
    Phone+1 781-259-1422

Summary

  • Dr. Robert Louis Steinbrook, MD is a board certified internist in Lincoln, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Wisconsin, and California.

Education & Training

  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineInternship, Transitional Year, 1979 - 1982
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2026
  • MA State Medical License
    MA State Medical License 1992 - 2026
  • WI State Medical License
    WI State Medical License 2014 - 2015
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • He Was Houston’s ‘Hero Doctor.' Now, He's Leading a Group of COVID Vaccine Critics Allied with RFK Jr
    He Was Houston’s ‘Hero Doctor.' Now, He's Leading a Group of COVID Vaccine Critics Allied with RFK JrDecember 5th, 2024
  • Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023
    Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023October 4th, 2024
  • FDA Loophole Raises Concerns About Oncology Drug Approvals and More
    FDA Loophole Raises Concerns About Oncology Drug Approvals and MoreAugust 20th, 2024